- Home
- PGEN vs EIM Comparison
PGEN vs EIM Comparison
Compare PGEN & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- EIM
- Stock Information
- Founded
- PGEN 1998
- EIM 2002
- Country
- PGEN United States
- EIM United States
- Employees
- PGEN N/A
- EIM N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- EIM Finance/Investors Services
- Sector
- PGEN Health Care
- EIM Finance
- Exchange
- PGEN Nasdaq
- EIM Nasdaq
- Market Cap
- PGEN 493.0M
- EIM 522.9M
- IPO Year
- PGEN N/A
- EIM N/A
- Fundamental
- Price
- PGEN $4.18
- EIM $9.69
- Analyst Decision
- PGEN Buy
- EIM
- Analyst Count
- PGEN 5
- EIM 0
- Target Price
- PGEN $7.50
- EIM N/A
- AVG Volume (30 Days)
- PGEN 15.4M
- EIM 215.2K
- Earning Date
- PGEN 08-12-2025
- EIM 01-01-0001
- Dividend Yield
- PGEN N/A
- EIM 4.32%
- EPS Growth
- PGEN N/A
- EIM N/A
- EPS
- PGEN N/A
- EIM N/A
- Revenue
- PGEN $4,340,000.00
- EIM N/A
- Revenue This Year
- PGEN $256.94
- EIM N/A
- Revenue Next Year
- PGEN $759.81
- EIM N/A
- P/E Ratio
- PGEN N/A
- EIM N/A
- Revenue Growth
- PGEN N/A
- EIM N/A
- 52 Week Low
- PGEN $0.65
- EIM $8.61
- 52 Week High
- PGEN $4.21
- EIM $10.51
- Technical
- Relative Strength Index (RSI)
- PGEN 88.14
- EIM 59.69
- Support Level
- PGEN $2.94
- EIM $9.49
- Resistance Level
- PGEN $3.34
- EIM $9.72
- Average True Range (ATR)
- PGEN 0.32
- EIM 0.09
- MACD
- PGEN 0.22
- EIM 0.00
- Stochastic Oscillator
- PGEN 99.00
- EIM 71.43
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About EIM Eaton Vance Municipal Bond
Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.